Sudarshan Pharma Industries Limited (BOM:543828)

BOM:543828 Revenue

In the fiscal year ending March 31, 2026, Sudarshan Pharma Industries had annual revenue of 7.12B INR with 40.93% growth. Sudarshan Pharma Industries had revenue of 2.25B in the quarter ending March 31, 2026, with 94.58% growth.

• Revenue: 7.12B
• Revenue Growth: +40.93%
• P/S Ratio: 1.02
• Revenue / Employee: 118.63M
• Employees: 60
• Market Cap: 7.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	7.12B	2.07B	40.93%
Mar 31, 2025	5.05B	415.07M	8.95%
Mar 31, 2024	4.64B	22.10M	0.48%
Mar 31, 2023	4.61B	1.04B	29.19%
Mar 31, 2022	3.57B	1.64B	84.52%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 6, 2026

Data Sources Report a data error